JPWO2013118744A1 - ロイコ型色原体含有水溶液の保存方法 - Google Patents
ロイコ型色原体含有水溶液の保存方法 Download PDFInfo
- Publication number
- JPWO2013118744A1 JPWO2013118744A1 JP2013557534A JP2013557534A JPWO2013118744A1 JP WO2013118744 A1 JPWO2013118744 A1 JP WO2013118744A1 JP 2013557534 A JP2013557534 A JP 2013557534A JP 2013557534 A JP2013557534 A JP 2013557534A JP WO2013118744 A1 JPWO2013118744 A1 JP WO2013118744A1
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- aqueous solution
- leuco chromogen
- chromogen
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007864 aqueous solution Substances 0.000 title claims abstract description 86
- 238000000034 method Methods 0.000 title claims abstract description 43
- -1 phenazine compound Chemical class 0.000 claims abstract description 36
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 31
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 150000002988 phenazines Chemical class 0.000 claims abstract description 9
- 150000002991 phenoxazines Chemical class 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims description 50
- 125000003342 alkenyl group Chemical group 0.000 claims description 34
- 125000000217 alkyl group Chemical group 0.000 claims description 33
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 20
- 125000003545 alkoxy group Chemical group 0.000 claims description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 16
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 claims description 13
- 229950000688 phenothiazine Drugs 0.000 claims description 13
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 claims description 9
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 claims description 8
- 230000000087 stabilizing effect Effects 0.000 claims description 8
- 150000001450 anions Chemical class 0.000 claims description 7
- XUJZNKFIBZHDKL-UHFFFAOYSA-N 2-[[3,7-bis(dimethylamino)phenothiazine-10-carbonyl]amino]acetic acid Chemical compound C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3N(C(=O)NCC(O)=O)C2=C1 XUJZNKFIBZHDKL-UHFFFAOYSA-N 0.000 claims description 5
- 230000006641 stabilisation Effects 0.000 abstract description 9
- 238000011105 stabilization Methods 0.000 abstract description 9
- CWLYDTVACYGEPD-UHFFFAOYSA-M sodium;2-[[3,7-bis(dimethylamino)phenothiazine-10-carbonyl]amino]acetate Chemical compound [Na+].C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3N(C(=O)NCC([O-])=O)C2=C1 CWLYDTVACYGEPD-UHFFFAOYSA-M 0.000 description 60
- 239000012736 aqueous medium Substances 0.000 description 14
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
- SVRNCBGWUMMBQB-UHFFFAOYSA-N 1-hydroxyphenazine Chemical compound C1=CC=C2N=C3C(O)=CC=CC3=NC2=C1 SVRNCBGWUMMBQB-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 238000004040 coloring Methods 0.000 description 6
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 6
- MASUWVVNWALEEM-UHFFFAOYSA-M 1-methoxy-5-methylphenazin-5-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2N=C3C(OC)=CC=CC3=[N+](C)C2=C1 MASUWVVNWALEEM-UHFFFAOYSA-M 0.000 description 5
- 102000013415 peroxidase activity proteins Human genes 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- OLAQMPNUMMADRD-UHFFFAOYSA-N 10-ethylphenoxazine Chemical compound C1=CC=C2N(CC)C3=CC=CC=C3OC2=C1 OLAQMPNUMMADRD-UHFFFAOYSA-N 0.000 description 3
- SQHWUYVHKRVCMD-UHFFFAOYSA-N 2-n,2-n-dimethyl-10-phenylphenazin-10-ium-2,8-diamine;chloride Chemical class [Cl-].C12=CC(N(C)C)=CC=C2N=C2C=CC(N)=CC2=[N+]1C1=CC=CC=C1 SQHWUYVHKRVCMD-UHFFFAOYSA-N 0.000 description 3
- GVTGSIMRZRYNEI-UHFFFAOYSA-N 5,10-dimethylphenazine Chemical compound C1=CC=C2N(C)C3=CC=CC=C3N(C)C2=C1 GVTGSIMRZRYNEI-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- AAAQKTZKLRYKHR-UHFFFAOYSA-N triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 description 3
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 2
- QZTKDVCDBIDYMD-UHFFFAOYSA-N 2,2'-[(2-amino-2-oxoethyl)imino]diacetic acid Chemical compound NC(=O)CN(CC(O)=O)CC(O)=O QZTKDVCDBIDYMD-UHFFFAOYSA-N 0.000 description 2
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 2
- SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 description 2
- LVQFQZZGTZFUNF-UHFFFAOYSA-N 2-hydroxy-3-[4-(2-hydroxy-3-sulfonatopropyl)piperazine-1,4-diium-1-yl]propane-1-sulfonate Chemical compound OS(=O)(=O)CC(O)CN1CCN(CC(O)CS(O)(=O)=O)CC1 LVQFQZZGTZFUNF-UHFFFAOYSA-N 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 2
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 description 2
- RZQXOGQSPBYUKH-UHFFFAOYSA-N 3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCC(CO)(CO)NCC(O)CS(O)(=O)=O RZQXOGQSPBYUKH-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- PJWWRFATQTVXHA-UHFFFAOYSA-N Cyclohexylaminopropanesulfonic acid Chemical compound OS(=O)(=O)CCCNC1CCCCC1 PJWWRFATQTVXHA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 2
- 239000006173 Good's buffer Substances 0.000 description 2
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 2
- GIZQLVPDAOBAFN-UHFFFAOYSA-N HEPPSO Chemical compound OCCN1CCN(CC(O)CS(O)(=O)=O)CC1 GIZQLVPDAOBAFN-UHFFFAOYSA-N 0.000 description 2
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 2
- DBXNUXBLKRLWFA-UHFFFAOYSA-N N-(2-acetamido)-2-aminoethanesulfonic acid Chemical compound NC(=O)CNCCS(O)(=O)=O DBXNUXBLKRLWFA-UHFFFAOYSA-N 0.000 description 2
- YNLCVAQJIKOXER-UHFFFAOYSA-N N-[tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid Chemical compound OCC(CO)(CO)NCCCS(O)(=O)=O YNLCVAQJIKOXER-UHFFFAOYSA-N 0.000 description 2
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 108091005995 glycated hemoglobin Proteins 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 125000005017 substituted alkenyl group Chemical group 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZIZMDHZLHJBNSQ-UHFFFAOYSA-N 1,2-dihydrophenazine Chemical group C1=CC=C2N=C(C=CCC3)C3=NC2=C1 ZIZMDHZLHJBNSQ-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ZPGZNKGKCSYBGK-UHFFFAOYSA-N 1-n-[4-(dimethylamino)phenyl]-4-n,4-n-dimethylbenzene-1,4-diamine Chemical compound C1=CC(N(C)C)=CC=C1NC1=CC=C(N(C)C)C=C1 ZPGZNKGKCSYBGK-UHFFFAOYSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- INEWUCPYEUEQTN-UHFFFAOYSA-N 3-(cyclohexylamino)-2-hydroxy-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CNC1CCCCC1 INEWUCPYEUEQTN-UHFFFAOYSA-N 0.000 description 1
- XCBLFURAFHFFJF-UHFFFAOYSA-N 3-[bis(2-hydroxyethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCCN(CCO)CC(O)CS(O)(=O)=O XCBLFURAFHFFJF-UHFFFAOYSA-N 0.000 description 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000007991 ACES buffer Substances 0.000 description 1
- 108700016232 Arg(2)-Sar(4)- dermorphin (1-4) Proteins 0.000 description 1
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 description 1
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 101710184216 Cardioactive peptide Proteins 0.000 description 1
- SDKQRNRRDYRQKY-UHFFFAOYSA-N Dioxacarb Chemical compound CNC(=O)OC1=CC=CC=C1C1OCCO1 SDKQRNRRDYRQKY-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000007998 bicine buffer Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 108010077372 mast cell degranulating peptide Proteins 0.000 description 1
- JSABTPDNEXHNOQ-UHFFFAOYSA-N n-phenylaniline;sodium Chemical compound [Na].C=1C=CC=CC=1NC1=CC=CC=C1 JSABTPDNEXHNOQ-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B17/00—Azine dyes
- C09B17/02—Azine dyes of the benzene series
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B21/00—Thiazine dyes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
[2] ロイコ型色原体を、フェナジン系化合物及びフェノキサジン系化合物からなる群より選ばれる少なくとも1種を含む水溶液中で共存させることを特徴とする、ロイコ型色原体の安定化方法。
[3] フェナジン系化合物が、一般式(I)
[4] フェノキサジン系化合物が、一般式(III)
[5] ロイコ型色原体が、フェノチアジン系色原体である[1]〜[4]のいずれかに記載の方法。
[6] フェノチアジン系色原体が、10−(カルボキシメチルアミノカルボニル)−3,7−ビス(ジメチルアミノ)フェノチアジンである[5]記載の方法。
[8] フェナジン系化合物が、一般式(I)
[9] フェノキサジン系化合物が、一般式(III)
[10] ロイコ型色原体が、フェノチアジン系色原体である[7]〜[9]のいずれかに記載の試薬。
[11] フェノチアジン系色原体が、10−(カルボキシメチルアミノカルボニル)−3,7−ビス(ジメチルアミノ)フェノチアジンである[10]記載の試薬。
本発明は、ロイコ型色原体含有水溶液の保存方法に関する。本発明のロイコ型色原体含有水溶液の保存方法により、水溶液中でロイコ型色原体が安定に保存される。本発明において、ロイコ型色原体が水溶液中で安定に保存されるとは、水溶液中でロイコ型色原体が熱に対して安定であるか、又は、光に対して安定であることをいい、ロイコ型色原体が水溶液中で光に対して安定であることが好ましい。本発明のロイコ型色原体含有水溶液の保存方法においては、フェナジン系化合物及びフェノキサジン系化合物からなる群より選ばれる少なくとも1種が、ロイコ型色原体含有水溶液に添加される。
本発明の液状試薬は、ロイコ型色原体と、フェナジン系化合物及びフェノキサジン系化合物からなる群より選ばれる少なくとも1種とを含有する液状試薬である。
Bis−Tris(pH7.0) 50mmol/L
DA−67 20μmol/L
フェナジン 10μmol/L
Bis−Tris(pH7.0) 50mmol/L
DA−67 20μmol/L
PMS 10μmol/L
Bis−Tris(pH7.0) 50mmol/L
DA−67 20μmol/L
1−メトキシPMS 10μmol/L
Bis−Tris(pH7.0) 50mmol/L
DA−67 20μmol/L
5,10−ジヒドロ−5,10−ジメチルフェナジン
10μmol/L
Bis−Tris(pH7.0) 50mmol/L
DA−67 20μmol/L
1−ヒドロキシフェナジン 10μmol/L
Bis−Tris(pH7.0) 50mmol/L
DA−67 20μmol/L
フェノキサジン 10μmol/L
Bis−Tris(pH7.0) 50mmol/L
DA−67 20μmol/L
10−エチルフェノキサジン 10μmol/L
以下の組成からなるDA−67含有水溶液を調製した。
DA−67 20μmol/L
実施例1で調製したDA−67含有水溶液に対して、1,300ルクスの光を10時間照射し、光によるDA−67の安定性を評価した。光照射後のDA−67含有水溶液をDA−67安定性評価用試料として用いた。
以下の組成からなるDA−67安定性測定用試薬を調製した。
<DA−67安定性測定用試薬>
Bis−Tris(pH7.0) 50mmol/L
BSA 0.005%
実施例1で調製した直後のDA−67含有水溶液30μLに(2)で調製したDA−67安定性測定用試薬120μLを添加し、37℃で5分間加温した後の溶液の吸光度(E直後)を、主波長660 nm、副波長800 nmで日立7170Sにて測定した。調製直後のDA−67含有水溶液の代わりに、(2)のDA−67安定性測定用試薬を用いて同様の測定を行い、吸光度(Eブランク)を測定した。E直後からEブランクを差し引き、調製直後のDA−67含有水溶液に対する吸光度(△E直後)とした。
実施例1のDA−67含有水溶液の代わりに、比較例1のDA−67含有水溶液を用いる以外は実施例8と同様の方法により△E1を測定した。その結果を第1表に示す。
Claims (11)
- ロイコ型色原体含有水溶液に、フェナジン系化合物及びフェノキサジン系化合物からなる群より選ばれる少なくとも1種を添加することを特徴とする、ロイコ型色原体含有水溶液の保存方法。
- ロイコ型色原体を、フェナジン系化合物及びフェノキサジン系化合物からなる群より選ばれる少なくとも1種を含む水溶液中で共存させることを特徴とする、ロイコ型色原体の安定化方法。
- フェナジン系化合物が、一般式(I)
- フェノキサジン系化合物が、一般式(III)
- ロイコ型色原体が、フェノチアジン系色原体である請求項1〜4のいずれかに記載の方法。
- フェノチアジン系色原体が、10−(カルボキシメチルアミノカルボニル)−3,7−ビス(ジメチルアミノ)フェノチアジンである請求項5記載の方法。
- ロイコ型色原体と、フェナジン系化合物及びフェノキサジン系化合物からなる群より選ばれる少なくとも1種とを含有する液状試薬。
- フェナジン系化合物が、一般式(I)
- フェノキサジン系化合物が、一般式(III)
- ロイコ型色原体が、フェノチアジン系色原体である請求項7〜9のいずれかに記載の試薬。
- フェノチアジン系色原体が、10−(カルボキシメチルアミノカルボニル)−3,7−ビス(ジメチルアミノ)フェノチアジンである請求項10記載の試薬。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012026214 | 2012-02-09 | ||
JP2012026214 | 2012-02-09 | ||
PCT/JP2013/052670 WO2013118744A1 (ja) | 2012-02-09 | 2013-02-06 | ロイコ型色原体含有水溶液の保存方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2013118744A1 true JPWO2013118744A1 (ja) | 2015-05-11 |
JP6152347B2 JP6152347B2 (ja) | 2017-06-21 |
Family
ID=48947505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013557534A Active JP6152347B2 (ja) | 2012-02-09 | 2013-02-06 | ロイコ型色原体含有水溶液の保存方法 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6152347B2 (ja) |
WO (1) | WO2013118744A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12049566B2 (en) | 2016-07-29 | 2024-07-30 | Hitachi Chemical Diagnostics Systems Co., Ltd. | Method for preserving leuco chromogen-containing aqueous solution |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0270761A (ja) * | 1988-07-05 | 1990-03-09 | Eastman Kodak Co | ロイコ染料を供給する還元可能な化合物ならびにそれを含有する分析組成物、要素および使用方法 |
JPH02142856A (ja) * | 1988-10-08 | 1990-05-31 | Hoechst Ag | ロイコ染料溶液の安定化法およびロイコ染料を含有する放射線重合性混合物 |
JPH063812A (ja) * | 1992-06-19 | 1994-01-14 | Konica Corp | 湿し水不要感光性平版印刷版 |
JPH10133328A (ja) * | 1996-09-05 | 1998-05-22 | E I Du Pont De Nemours & Co | 改良されたロイコ染料を含む貯蔵安定な光画像形成性ロイコ染料/光オキシダント組成物 |
JP2003185619A (ja) * | 2001-09-14 | 2003-07-03 | Bayer Corp | 分析対象物を検出するための試薬及び方法ならびに分析対象物を検出するための試薬を含む装置 |
WO2008076888A1 (en) * | 2006-12-18 | 2008-06-26 | 3M Innovative Properties Company | Chemical indicator test strip |
WO2009069309A1 (ja) * | 2007-11-28 | 2009-06-04 | Sekisui Medical Co., Ltd. | フェノチアジン系酸化発色剤含有水溶液の安定化方法 |
WO2009116575A1 (ja) * | 2008-03-19 | 2009-09-24 | アークレイ株式会社 | 発色剤の安定化剤およびその用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9818821D0 (en) * | 1998-08-29 | 1998-10-21 | Ciba Sc Holding Ag | Novel monophase solid solutions |
CA2806264A1 (en) * | 2010-08-11 | 2012-02-16 | Kyowa Medex Co., Ltd. | Method for preserving aqueous solution containing leuco chromogen |
-
2013
- 2013-02-06 JP JP2013557534A patent/JP6152347B2/ja active Active
- 2013-02-06 WO PCT/JP2013/052670 patent/WO2013118744A1/ja active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0270761A (ja) * | 1988-07-05 | 1990-03-09 | Eastman Kodak Co | ロイコ染料を供給する還元可能な化合物ならびにそれを含有する分析組成物、要素および使用方法 |
JPH02142856A (ja) * | 1988-10-08 | 1990-05-31 | Hoechst Ag | ロイコ染料溶液の安定化法およびロイコ染料を含有する放射線重合性混合物 |
JPH063812A (ja) * | 1992-06-19 | 1994-01-14 | Konica Corp | 湿し水不要感光性平版印刷版 |
JPH10133328A (ja) * | 1996-09-05 | 1998-05-22 | E I Du Pont De Nemours & Co | 改良されたロイコ染料を含む貯蔵安定な光画像形成性ロイコ染料/光オキシダント組成物 |
JP2003185619A (ja) * | 2001-09-14 | 2003-07-03 | Bayer Corp | 分析対象物を検出するための試薬及び方法ならびに分析対象物を検出するための試薬を含む装置 |
WO2008076888A1 (en) * | 2006-12-18 | 2008-06-26 | 3M Innovative Properties Company | Chemical indicator test strip |
WO2009069309A1 (ja) * | 2007-11-28 | 2009-06-04 | Sekisui Medical Co., Ltd. | フェノチアジン系酸化発色剤含有水溶液の安定化方法 |
JP2011026359A (ja) * | 2007-11-28 | 2011-02-10 | Sekisui Medical Co Ltd | フェノチアジン系酸化発色剤含有水溶液の安定化方法 |
WO2009116575A1 (ja) * | 2008-03-19 | 2009-09-24 | アークレイ株式会社 | 発色剤の安定化剤およびその用途 |
Also Published As
Publication number | Publication date |
---|---|
WO2013118744A1 (ja) | 2013-08-15 |
JP6152347B2 (ja) | 2017-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5955220B2 (ja) | 糖化ヘモグロビンの測定方法 | |
JP5871800B2 (ja) | 糖化ヘモグロビンの測定方法 | |
JP5255283B2 (ja) | 発色剤の液体試薬、及び、その安定化方法 | |
WO2012173185A1 (ja) | 糖化ヘモグロビンの測定方法、測定試薬、及び、測定キット | |
JP6004942B2 (ja) | 測定対象成分の測定方法 | |
JP6152347B2 (ja) | ロイコ型色原体含有水溶液の保存方法 | |
JP5737659B2 (ja) | ロイコ型色原体含有水溶液の保存方法 | |
JP6343565B2 (ja) | ロイコ型色原体含有水溶液の保存方法 | |
JP5902098B2 (ja) | ロイコ型色原体含有水溶液の保存方法 | |
KR102033197B1 (ko) | 아스코르브산옥시다아제의 안정화 방법 | |
JP7047759B2 (ja) | ロイコ型色原体含有水溶液の保存方法 | |
JP2019196331A (ja) | 精製された4−アミノアンチピリンの製造方法及び生成された4−アミノアンチピリン |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20151215 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161101 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170125 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170201 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170509 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170529 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6152347 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |